Updates are available Correction dated 2022-05-09
Click to view Correction: https://doi.org/10.1038/s41388-022-02342-6
-
Authors
Odeniyide, Patience https://orcid.org/0000-0002-9783-1657
Yohe, Marielle E.
Pollard, Kai
Vaseva, Angelina V.
Calizo, Ana
Zhang, Lindy
Rodriguez, Fausto J. https://orcid.org/0000-0001-8662-1219
Gross, John M.
Allen, Amy N.
Wan, Xiaolin
Somwar, Romel
Schreck, Karisa C. https://orcid.org/0000-0001-7181-3269
Kessler, Linda
Wang, Jiawan
Pratilas, Christine A. https://orcid.org/0000-0002-7116-0605
- License Information
-
More Information
Article History
Received: 5 February 2021
Revised: 25 March 2022
Accepted: 30 March 2022
First Online: 22 April 2022
Change Date: 9 May 2022
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41388-022-02342-6
Competing interests
: LK is an employee of Kura Oncology. CAP consulting fees from Genentech/Roche and Day One Therapeutics; research grant support from Kura Oncology and Novartis Institute for Biomedical Research. RS has received research support from Merus, Helsinn Healthcare, Loxo Oncology and Elevation Oncology Inc, unrelated to the studies described in this manuscript. The remaining authors have declared that no conflicts of interests exist.
